Quantitative Systematic Strategies’s Novo Nordisk NVO Stock Holding History

Quantitative Systematic Strategies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,286	Closed	-$460K	–	608
2020 Q1	$460K	Sell	15,286 -31,254	-67%	-$931K	0.38%	94
2019 Q4	$1.35M	Buy	+46,540	New	+$1.29M	0.2%	154
2018 Q4	–	Sell	-12,122	Closed	-$286K	–	809
2018 Q3	$286K	Buy	+12,122	New	+$296K	0.05%	430
2018 Q2	–	Sell	-10,648	Closed	-$262K	–	740
2018 Q1	$262K	Buy	+10,648	New	+$280K	0.06%	495

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Quantitative Systematic Strategies's NVO Position: Q2 2020 in Review

Quantitative Systematic Strategies sold out of Novo Nordisk (NVO) in Q2 2020, closing a stake of 15,286 shares — an estimated $460K sold.

Quantitative Systematic Strategies first reported a position in NVO in Q1 2018 and held it in 4 quarters. The position peaked at $1.35M in Q4 2019. 660 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

Quantitative Systematic Strategies reported no remaining Novo Nordisk position as of Q2 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 15,286 Novo Nordisk shares in Q2 2020, an estimated $460K.
Quantitative Systematic Strategies first reported a position in Novo Nordisk in Q1 2018 and held it in 4 quarters.
Quantitative Systematic Strategies's Novo Nordisk position peaked at $1.35M in Q4 2019.
660 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2020, filed 4 Aug 2020.